Annual CFF
-$5.24B$825.72M+13.61%
Summary
- Current Value
- As of today, GSK annual cash from financing is -$5.24B, up +13.61% on
- Historical Performance
- GSK annual cash from financing is up +44.14% over the past 3 years, and down -338.13% over the past 5 years
- All-Time High Comparison
- GSK annual cash from financing is currently -206.96% below its historical high of $4.90B set on
- 3-Year Low Comparison
- GSK annual cash from financing is +13.61% above its 3-year low of -$6.07B reached on
- Sector Comparison
- GSK annual cash from financing is higher than 0.85% of companies in Healthcare sector
Cash From Financing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | -$5.24B | +13.6% | +44.1% | -338.1% | -67.5% | |
| Quarterly Cash From Financing | -$1.71B | -10.9% | +2.3% | +67.9% | -42.9% | |
| TTM Cash From Financing | -$4.09B | +52.0% | -10000.0% | +67.1% | +47.9% | |
| Price | $48.22 | +44.2% | +36.3% | +24.4% | +27.6% | |
| Annual Cash From Operations | $7.78B | -1.4% | -21.4% | -15.4% | -30.8% | |
| Annual Cash From Investing | -$1.77B | +26.2% | +28.0% | +74.5% | +72.5% | |
| Annual Dividends Paid | $3.12B | +11.8% | -43.2% | -38.1% | -33.7% | |
| Annual Total Debt | $21.27B | -7.4% | -35.0% | -47.4% | -19.0% | |
| Shares Outstanding | 2.01B | -1.5% | -1.8% | -0.1% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.05B | N/A | -355.9% |
| 5Y | $2.05B | -355.9% | |
| All | $4.90B | -207.0% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$6.07B | +13.6% | |
| 5Y | -$11.89B | N/A | +55.9% |
| All | -$11.89B | +55.9% |
Cash From Financing History
FAQ
What is the current annual cash from financing of GSK?
As of today, GSK annual cash from financing is -$5.24B
What is 1-year change in GSK annual cash from financing?
GSK annual cash from financing is up +13.61% year-over-year
What is 3-year change in GSK annual cash from financing?
GSK annual cash from financing is up +44.14% over the past 3 years
How far is GSK annual cash from financing from its all-time high?
GSK annual cash from financing is currently -206.96% below its historical high of $4.90B set on December 31, 2018
How does GSK annual cash from financing rank versus sector peers?
GSK annual cash from financing is higher than 0.85% of companies in Healthcare sector
When is GSK next annual earnings release?
The next annual earnings release for GSK is on
Quarterly CFF
-$1.71B$1.07B+38.55%
Summary
- Current Value
- As of today, GSK quarterly cash from financing is -$1.71B, up +38.55% on
- Historical Performance
- GSK quarterly cash from financing is down -10.93% year-over-year, and up +2.28% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from financing is currently -114.68% below its historical high of $11.63B set on
- 3-Year Low Comparison
- GSK quarterly cash from financing is +58.00% above its 3-year low of -$4.06B reached on
- Sector Comparison
- GSK quarterly cash from financing is higher than 1.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | -$1.71B | +38.5% | -10.9% | +2.3% | +67.9% | |
| Annual Cash From Financing | -$5.24B | – | +13.6% | +44.1% | -338.1% | |
| TTM Cash From Financing | -$4.09B | -4.3% | +52.0% | -10000.0% | +67.1% | |
| Price | $48.22 | +9.3% | +44.2% | +36.3% | +24.4% | |
| Quarterly Cash From Operations | $3.03B | +22.8% | +11.2% | +108.8% | +192.9% | |
| Quarterly Cash From Investing | -$2.15B | -160.6% | -125.7% | +57.1% | -199.8% | |
| Quarterly Dividends Paid | $905.47M | +4.3% | +15.8% | +13.3% | -23.6% | |
| Quarterly Total Debt | $23.90B | +0.5% | +10.9% | -3.2% | -34.6% | |
| Shares Outstanding | 2.01B | – | -1.5% | -1.8% | -0.1% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.24B | -237.6% | |
| 3Y | $1.24B | -237.6% | |
| 5Y | $10.79B | -115.8% | |
| All | $11.63B | -114.7% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.78B | +38.5% | |
| 3Y | -$4.06B | +58.0% | |
| 5Y | -$5.70B | +70.1% | |
| All | -$5.70B | +70.1% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of GSK?
As of today, GSK quarterly cash from financing is -$1.71B
What is GSK quarterly cash from financing most recent change?
GSK quarterly cash from financing was up +38.55% on September 1, 2025
What is 1-year change in GSK quarterly cash from financing?
GSK quarterly cash from financing is down -10.93% year-over-year
How far is GSK quarterly cash from financing from its all-time high?
GSK quarterly cash from financing is currently -114.68% below its historical high of $11.63B set on June 30, 2018
How does GSK quarterly cash from financing rank versus sector peers?
GSK quarterly cash from financing is higher than 1.27% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM CFF
-$4.09B$168.18M-4.29%
Summary
- Current Value
- As of today, GSK TTM cash from financing is -$4.09B, down -4.29% on
- Historical Performance
- GSK TTM cash from financing is up +51.97% year-over-year, and down -29124.82% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from financing is currently -140.42% below its historical high of $10.11B set on
- 3-Year Low Comparison
- GSK TTM cash from financing is +55.27% above its 3-year low of -$9.14B reached on
- Sector Comparison
- GSK TTM cash from financing is higher than 1.63% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$4.09B | -4.3% | +52.0% | -10000.0% | +67.1% | |
| Annual Cash From Financing | -$5.24B | – | +13.6% | +44.1% | -338.1% | |
| Quarterly Cash From Financing | -$1.71B | +38.5% | -10.9% | +2.3% | +67.9% | |
| Price | $48.22 | +9.3% | +44.2% | +36.3% | +24.4% | |
| TTM Cash From Operations | $9.75B | +3.2% | +12.8% | -11.8% | +7.8% | |
| TTM Cash From Investing | -$6.06B | -24.6% | -10000.0% | +44.3% | -361.7% | |
| TTM Dividends Paid | $3.37B | +3.8% | +12.6% | -29.6% | -31.8% | |
| Quarterly Total Debt | $23.90B | +0.5% | +10.9% | -3.2% | -34.6% | |
| Shares Outstanding | 2.01B | – | -1.5% | -1.8% | -0.1% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.80B | -46.0% | |
| 3Y | $2.03B | N/A | -301.2% |
| 5Y | $3.19B | -228.0% | |
| All | $10.11B | -140.4% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$5.29B | N/A | +22.8% |
| 3Y | -$9.14B | +55.3% | |
| 5Y | -$12.43B | +67.1% | |
| All | -$12.43B | +67.1% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of GSK?
As of today, GSK TTM cash from financing is -$4.09B
What is GSK TTM cash from financing most recent change?
GSK TTM cash from financing was down -4.29% on September 1, 2025
What is 1-year change in GSK TTM cash from financing?
GSK TTM cash from financing is up +51.97% year-over-year
How far is GSK TTM cash from financing from its all-time high?
GSK TTM cash from financing is currently -140.42% below its historical high of $10.11B set on March 31, 2019
How does GSK TTM cash from financing rank versus sector peers?
GSK TTM cash from financing is higher than 1.63% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk